Global Osteoarthritis Therapeutics Market Projected to Surpass $12.22 Billion by 2029 with 8.3% Annual Growth

What Are the Market Size and Growth Forecast for the Osteoarthritis Therapeutics Market?
The market for osteoarthritis treatments has seen considerable growth in the recent past. It is expected to rise from $8.17 billion in 2024 to $8.87 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%. Factors contributing to the growth experienced in the historic period include an aging population, enhanced drug delivery systems, increased awareness and diagnosis, the creation of innovative treatments, and an escalation in obesity rates.

In the forthcoming years, robust growth is expected for the osteoarthritis therapeutics market, with its size projected to reach $12.22 billion by the year 2029, portraying a compound annual growth rate (CAGR) of 8.3%. Factors contributing to this projected growth during the forecast period include an upsurge in obesity rates, enhancements in treatment methods, incremental awareness and diagnoses, the advent of disease-modifying osteoarthritis drugs (DMOADs), and financial support from both government and private sectors for research purposes. Emerging trends during this forecast period encompass a heightened emphasis on personalized medicine, the development of regenerative therapies, a broadening range of pain management strategies, support from government and regulatory bodies, and soaring demand in burgeoning markets.

What Is Contributing to the Growth of the Osteoarthritis Therapeutics Market?
The escalation of sports-related injuries is projected to fuel the expansion of the osteoarthritis therapeutics market. Sports injury is a term that refers to any damage or harm that befalls during sports or athletic pursuits. The intensity of these injuries can vary from minor to major and can impact different parts of the body. The surge in sports injuries primarily stems from the increased involvement in sports and the escalating intensity and competition of these pursuits. Osteoarthritis therapeutic treatments are employed in sports injuries for easing pain and inflammation, and to enhance joint function in athletes who are experiencing joint degeneration. For instance, the National Safety Council, a nonprofit organization from the US dedicated to promoting health and safety, reported a 12% increase in sports and recreational injuries in 2022. Hence, the increasing trend in sports injuries is fueling the growth of the osteoarthritis therapeutics market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19634&type=smp

Which Key Market Leaders Are Driving Osteoarthritis Therapeutics Industry Growth?
Major companies operating in the osteoarthritis therapeutics market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited, Zimmer Biomet Holdings Inc., Horizon Therapeutics plc, Taisho Pharmaceutical Co. Ltd., Ferring Pharmaceuticals, Galapagos NV, Bioventus LLC, Flexion Therapeutics Inc., Anika Therapeutics Inc., Seikagaku Corporation, Samumed LLC, Orthogen AG, Kolon Life Science Inc.

What Are the Emerging Trends in the Osteoarthritis Therapeutics Industry?
Large corporations within the osteoarthritis therapeutics market are concentrating their efforts on developing ground-breaking solutions, such as fresh innovations for the regeneration of tissue in cases of osteoarthritis. This refers to the method of fixing or substituting damaged cartilage and joint tissues to recover normal operation and relieve discomfort. For example, the Advanced Research Projects Agency for Health (ARPA-H), a US government entity, unveiled the Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) in May 2023. The NITRO program, launched by ARPA-H, emphasizes the development of state-of-the-art injectable treatments designed to stimulate cartilage healing by utilizing biological pathways akin to those found in embryonic development. Distinguished attributes include a collective multimodal tactic among research groups and sophisticated testing processes like "joint-on-a-chip" platforms that simulate joint conditions, striving to produce regenerative solutions that tackle the root causes of osteoarthritis.

What Are the Main Segments in the Osteoarthritis Therapeutics Market?
The osteoarthritis therapeuticsmarket covered in this report is segmented -

1) Drug Type: Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids, Other Drug Types
2) By Anatomy: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Other Anatomies
3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route
4) By Sales Channel: Prescription Drugs, Over-the-Counter Drugs
5) By End-use: Hospital Pharmacies, Retail Pharmacies, Other End-uses

Subsegments:
1) Viscosupplementation Agents: Hyaluronic Acid Injections, Single-Injection Products, Multi-Injection Products
2) Nonsteroidal Anti-inflammatory Drugs: Oral NSAIDs, Topical NSAIDs, COX-2 Inhibitors
3) Analgesics: Opioid Analgesics, Non-Opioid Analgesics, Topical Analgesics
4) Corticosteroids: Injectable Corticosteroids, Oral Corticosteroids, Intra-Articular Corticosteroids
5) Other Drug Types: Disease-Modifying Osteoarthritis Drugs (DMOADs), Platelet-Rich Plasma Therapy, Stem Cell Therapy

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/osteoarthritis-therapeutics-global-market-report

Which Geographic Area Leads the Osteoarthritis Therapeutics Market?
North America was the largest region in the osteoarthritis therapeutics market in 2022. The regions covered in the osteoarthritis therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Osteoarthritis Therapeutics Global Market Report?

- Market Size Analysis: Analyze the Osteoarthritis Therapeutics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Osteoarthritis Therapeutics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Osteoarthritis Therapeutics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Osteoarthritis Therapeutics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19634

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.